Author

Ana Carrasco del Amor

Observed name: Ana Maria Carrasco Del Amor

Institution: Linköping University

Observed institution: Linköping University

ORCID: 0000-0002-5145-9327

Observed ORCID: 0000-0002-5145-9327

OpenAlex ID: A5113031435

Nonionic Surfactants can Modify the Thermal Stability of Globular and Membrane Proteins Interfering with the Thermal Proteome Profiling Principles to Identify Protein Targets

2023 · Emmanuel Berlin, Veronica Lizano-Fallas, et al. · Analytical Chemistry · 24

Application of Bioactive Thermal Proteome Profiling to Decipher the Mechanism of Action of the Lipid Lowering 132-Hydroxy-pheophytin Isolated from a Marine Cyanobacteria

2019 · Ana Carrasco del Amor, Sara Freitas, et al. · Marine Drugs · 20

Prediction of Molecular Initiating Events for Adverse Outcome Pathways Using High-Throughput Identification of Chemical Targets

2023 · Veronica Lizano-Fallas, Ana Carrasco del Amor, et al. · Toxics · 12

Systematic analysis of chemical-protein interactions from zebrafish embryo by proteome-wide thermal shift assay, bridging the gap between molecular interactions and toxicity pathways

2021 · Veronica Lizano-Fallas, Ana Carrasco del Amor, et al. · Journal of Proteomics · 10

Predictive toxicology of chemical mixtures using proteome-wide thermal profiling and protein target properties

2024 · Veronica Lizano-Fallas, Ana Carrasco del Amor, et al. · Chemosphere · 6

A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers

2024 · Filippo Spriano, Giulio Sartori, et al. · Haematologica · 5

Insights into the mechanism of action of the chlorophyll derivative 13--hydroxypheophytine a on reducing neutral lipid reserves in zebrafish larvae and mice adipocytes

2023 · Ana Carrasco del Amor, Rene Hernandez Bautista, et al. · European Journal of Pharmacology · 5

Proteome integral solubility alteration assay combined with multi-criteria decision-making analysis for developing adverse outcome pathways

2022 · Veronica Lizano-Fallas, Ana Carrasco del Amor, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1

Abstract 1817: EG-011 is a first-in-class Wiskott-Aldrich syndrome protein (WASp) activator with anti-tumor activity

2022 · Filippo Spriano, Laura Barnabei, et al. · Cancer Research

Works count: 9

Citation count: 83

H-index: 5

I10-index: 4